CoChat

Plasma β-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions During Improved, Short-Term Glycemic Control in Diabetes Mellitus

Rosove, Michael H, Frank, Harrison J L, Harwig, Sylvia S L · 1984 · Diabetes Care
Cited by 62

The DOI matches its Crossref record.

Abstract

To determine the effect of improved, short-term glycemic control on various functions of hemostasis in insulin-dependent diabetes, we measured changes in plasma fibrinogen, fibrinopeptide A (FPA), functional antithrombin III (AT-III), factor VIII:ristocetin cofactor (VIIIRCoF), beta-thromboglobulin (BTG), platelet factor 4 (PF4), and platelet aggregation responses to ADP and collagen in 12 patients with low or undetectable stimulated (postprandial) serum C-peptide levels during 4–8 wk (median, 6 wk) of treatment with constant subcutaneous insulin infusion. Mean plasma fibrinogen, FPA, AT-III, VIIIRCoF , and BTG at baseline were elevated compared with normal. Three patients had heightened platelet responses to ADP that did not correlate to other indicators of a hypercoagulable state; the affected patients, in fact, had significantly lower plasma BTG (25.5 ± 5.3 [SEM] versus 44.6 ± 4.6 ng/ml, P < 0.05) and FPA (1.1 ± 0.1 versus 2.5 ± 0.5 ng/ml, P < 0.05) than the remaining patients. Patients with clinically evident vascular disease had higher baseline plasma BTG and FPA than those without vascular disease (44.6 ± 5.4 versus 30.2 ± 4.6, and 2.6 ± 0.6 versus 1.3 ± 0.2 ng/ml, P < 0.05, respectively). During treatment, all patients had declining blood glucose (200 ± 18 to 102 ± 5 mg/dl, P < 0.001) and HbA1 (11.8 ± 0.6 to 10.2 ± 0.4%, P < 0.005). No statistically significant changes in hemostaticfunctions were noted. During treatment, one patient had an acute myocardial infarction. It appears that short-term glycemic control alone in insulin-dependent diabetes does not exert a remarkable ameliorative effect on some aspects of hemostatic hyperfunction as defined by currently available, sensitive laboratory tests. It remains to be determined whether excellent long-range control, taking into consideration the extent of pre-existing vascular disease, might be more successful.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.7.2.174

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 62

Metadata

Authors
Rosove, M. H., Frank, H. J. L., & Harwig, S. S. L.
Venue
Diabetes Care
Published
1984-03-01
Volume
7
Issue
2
Pages
174-179
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2065645998
Cited by
62
References
0
FWCI
1.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma β-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions During Improved, Short-Term Glycemic Control in Diabetes Mellitus. https://app.cochat.ai/papers/10.2337/diacare.7.2.174
The paper
Rosove, M. H., Frank, H. J. L., & Harwig, S. S. L. (1984). Plasma β-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions During Improved, Short-Term Glycemic Control in Diabetes Mellitus. Diabetes Care. https://doi.org/10.2337/diacare.7.2.174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.